Gene therapy modifies DNA within cells to treat genetic diseases, with recent breakthroughs including CRISPR-based treatments and CAR-T therapy for cancer.
Gene therapy represents one of the most exciting frontiers in modern medicine, offering the potential to treat or even cure genetic diseases by modifying the DNA within a patient's cells. Unlike conventional treatments that manage symptoms, gene therapy addresses the root cause of disease at the molecular level.
The basic principle involves introducing, altering, or replacing genetic material within a patient's cells to correct a disease-causing mutation. Viral vectors, modified viruses that have been stripped of their ability to cause disease, are commonly used to deliver therapeutic genes into target cells.
In 2023, the first CRISPR-based therapy received regulatory approval for treating sickle cell disease, a condition affecting millions of people worldwide. CRISPR-Cas9 acts as molecular scissors that can precisely cut and edit DNA sequences. This breakthrough allows scientists to correct the defective gene responsible for the disease.
Gene therapy has shown remarkable results in treating inherited blindness. Luxturna, approved by the FDA, delivers a functional copy of a defective gene to retinal cells, restoring vision in patients with a rare form of inherited retinal dystrophy. Clinical trials are underway for gene therapies targeting muscular dystrophy and cystic fibrosis.
Cancer treatment has been revolutionized by CAR-T cell therapy, where a patient's own immune cells are genetically modified to recognize and attack cancer cells. This personalized approach has produced remarkable remission rates in certain blood cancers that were previously considered untreatable.
Despite its promise, gene therapy faces significant challenges. Long-term effects remain uncertain, and delivery to sufficient numbers of target cells is technically difficult. Ethical concerns about germline editing, which would pass genetic changes to future generations, continue to generate intense debate.
This piece is graded at CEFR level C1, it belongs to medicine.
ژن‌درمانی یکی از هیجان‌انگیزترین مرزهای پزشکی مدرن است و با اصلاح DNA درون سلول‌های بیمار، پتانسیل درمان یا حتی معالجه بیماری‌های ژنتیکی را ارائه می‌دهد.
اصل اساسی شامل معرفی، تغییر یا جایگزینی مواد ژنتیکی درون سلول‌های بیمار برای اصلاح جهش‌های ایجادکننده بیماری است.
در سال ۲۰۲۳، اولین درمان مبتنی بر CRISPR برای درمان کم‌خونی داسی‌شکل تأییدیه نظارتی دریافت کرد. CRISPR-Cas9 مانند قیچی‌های مولکولی عمل می‌کند که می‌تواند توالی‌های DNA را به‌دقت برش دهد.
ژن‌درمانی نتایج قابل توجهی در درمان نابینایی ارثی نشان داده است. Luxturna که توسط FDA تأیید شده، نسخه عملکردی ژن معیوب را به سلول‌های شبکیه منتقل می‌کند.
درمان سرطان توسط درمان سلول‌های CAR-T متحول شده است. علی‌رغم وعده‌اش، ژن‌درمانی با چالش‌های قابل توجهی از جمله نگرانی‌های اخلاقی در مورد ویرایش خط‌گرم‌لاین مواجه است.
More english articles on lienguaflow.ir/articles — free English practice for Persian speakers.